The Stericlean six-axis robots from Stäubli are the first vapor hydrogen peroxide resistant robots, allowing for automated operations in an isolator or cleanroom environment.
The CyBi-QuadStack is a high capacity bench top solution for microplate storage. With four stacker chimneys, the CyBi-QuadStack offers a compact setup with a capacity of up to 260 plates.
Micronic North America has introduced the Trinean DropSense96 multichannel spectrophotometer for DNA/RNA/protein quantification.
Tomtec believes that dried blood spots will create a paradigm change for bioanalytical analysis. The company’s DBS slide takes the place of the paper card. It uses the same low cost automation that Kodak used for 35mm color slide projection.
ProFACT Proteomics and its partner in research consumables, Biotech Support Group LLC, have introduced a new reagent kit called KinaSorb, for the enrichment and isolation of kinases.
Thermo Fisher Scientific Inc. announced its its Heratherm ovens, available in three different models: General Protocol, Advanced Protocol, and Advanced Protocol Security.
Scientists have identified a protein that acts as a "master switch" in certain white blood cells, determining whether they promote or inhibit inflammation.
Orthopedic scientists are a step closer to developing a vaccine to prevent life-threatening methicillin-resistant staphylococcus aureus infections following bone and joint surgery.
Molecular Profiles announces the expansion of its service offering to include new manufacturing capabilities, enabling the company to handle larger projects for pharmaceutical clients from preformulation through to Phase IIa.
Domain Therapeutics announced that an exclusive development and licensing agreement with Merck Serono was signed to develop metabotropic glutamate receptor 4 positive allosteric modulator drugs targeting Parkinson’s disease and other neurodegenerative diseases.
Omthera Pharmaceuticals, Inc. announced data from its ECLIPSE trial, designed to evaluate the bioavailability of Epanova, the company’s lead compound for treating very high triglycerides, compared to Lovaza, the leading prescription Omega 3.
Pharmaceutical company GlaxoSmithKline PLC said it will take a $3.4 billion charge against earnings in the fourth quarter to provide for litigation over its diabetes drug, Avandia.
A new study provides a rational for treating breast cancer by combining two kinds of targeted agents, one that inhibits an overactive, cancer-causing pathway in cancer cells and one that reverses changes that silence genes that normally prevent cancer.
Johnson & Johnson said it is recalling nearly 47 million packages of Tylenol, Sudafed and other nonprescription drugs manufactured at a Pennsylvania facility that has already been subject to a series of massive recalls.
Genedata, a provider of advanced software solutions for drug discovery and life science research, has announced the ninth version of Genedata Screener, a comprehensive software system for high content data analysis.